347 related articles for article (PubMed ID: 20951774)
1. Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.
Klein RC; Mace BE; Moore SD; Sullivan PM
Neuroscience; 2010 Dec; 171(4):1265-72. PubMed ID: 20951774
[TBL] [Abstract][Full Text] [Related]
2. Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice.
Klein RC; Acheson SK; Mace BE; Sullivan PM; Moore SD
Neurobiol Aging; 2014 Sep; 35(9):2046-52. PubMed ID: 24698766
[TBL] [Abstract][Full Text] [Related]
3. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
4. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.
Dumanis SB; Tesoriero JA; Babus LW; Nguyen MT; Trotter JH; Ladu MJ; Weeber EJ; Turner RS; Xu B; Rebeck GW; Hoe HS
J Neurosci; 2009 Dec; 29(48):15317-22. PubMed ID: 19955384
[TBL] [Abstract][Full Text] [Related]
5. Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.
Woody SK; Zhou H; Ibrahimi S; Dong Y; Zhao L
J Alzheimers Dis; 2016 Jun; 53(3):1015-31. PubMed ID: 27340853
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene.
Sun GZ; He YC; Ma XK; Li ST; Chen DJ; Gao M; Qiu SF; Yin JX; Shi J; Wu J
CNS Neurosci Ther; 2017 Sep; 23(9):748-758. PubMed ID: 28786172
[TBL] [Abstract][Full Text] [Related]
8. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology.
Wang C; Wilson WA; Moore SD; Mace BE; Maeda N; Schmechel DE; Sullivan PM
Neurobiol Dis; 2005 Mar; 18(2):390-8. PubMed ID: 15686968
[TBL] [Abstract][Full Text] [Related]
9. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.
Bour A; Grootendorst J; Vogel E; Kelche C; Dodart JC; Bales K; Moreau PH; Sullivan PM; Mathis C
Behav Brain Res; 2008 Nov; 193(2):174-82. PubMed ID: 18572260
[TBL] [Abstract][Full Text] [Related]
10. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
11. ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro.
Nwabuisi-Heath E; Rebeck GW; Ladu MJ; Yu C
ASN Neuro; 2014 Jan; 6(1):e00134. PubMed ID: 24328732
[TBL] [Abstract][Full Text] [Related]
12. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
[TBL] [Abstract][Full Text] [Related]
13. APOE genotype alters glial activation and loss of synaptic markers in mice.
Zhu Y; Nwabuisi-Heath E; Dumanis SB; Tai LM; Yu C; Rebeck GW; LaDu MJ
Glia; 2012 Apr; 60(4):559-69. PubMed ID: 22228589
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.
Bell RD; Winkler EA; Singh I; Sagare AP; Deane R; Wu Z; Holtzman DM; Betsholtz C; Armulik A; Sallstrom J; Berk BC; Zlokovic BV
Nature; 2012 May; 485(7399):512-6. PubMed ID: 22622580
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E2 Expression Alters Endosomal Pathways in a Mouse Model With Increased Brain Exosome Levels During Aging.
Peng KY; Liemisa B; Pasato J; D'Acunzo P; Pawlik M; Heguy A; Penikalapati SC; Labuza A; Pidikiti H; Alldred MJ; Ginsberg SD; Levy E; Mathews PM
Traffic; 2024 May; 25(5):e12937. PubMed ID: 38777335
[TBL] [Abstract][Full Text] [Related]
18. Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.
East BS; Fleming G; Peng K; Olofsson JK; Levy E; Mathews PM; Wilson DA
Neuroscience; 2018 Jun; 380():103-110. PubMed ID: 29678753
[TBL] [Abstract][Full Text] [Related]
19. Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines.
Sepulveda J; Luo N; Nelson M; Ng CAS; Rebeck GW
J Neurochem; 2022 Nov; 163(3):247-259. PubMed ID: 35838553
[TBL] [Abstract][Full Text] [Related]
20. Extra-Hippocampal Learning Deficits in Young Apolipoprotein E4 Mice and Their Synaptic Underpinning.
Har-Paz I; Roisman N; Michaelson DM; Moran A
J Alzheimers Dis; 2019; 72(1):71-82. PubMed ID: 31561365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
